These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24832624)

  • 1. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
    Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
    J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism.
    Kawai H; Makino Y; Hirobe M; Ohta S
    J Neurochem; 1998 Feb; 70(2):745-51. PubMed ID: 9453570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
    Xilouri M; Kyratzi E; Pitychoutis PM; Papadopoulou-Daifoti Z; Perier C; Vila M; Maniati M; Ulusoy A; Kirik D; Park DS; Wada K; Stefanis L
    Hum Mol Genet; 2012 Feb; 21(4):874-89. PubMed ID: 22076440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
    Kabuta T; Setsuie R; Mitsui T; Kinugawa A; Sakurai M; Aoki S; Uchida K; Wada K
    Hum Mol Genet; 2008 May; 17(10):1482-96. PubMed ID: 18250096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter and catechol-O-methyltransferase activities are required for the toxicity of 1-(3',4'-dihydroxybenzyl)-1,2,3, 4-tetrahydroisoquinoline.
    Kawai H; Kotake Y; Ohta S
    Chem Res Toxicol; 2000 Dec; 13(12):1294-301. PubMed ID: 11123971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-Mercuration of ubiquitin carboxyl-terminal hydrolase L1 through Cys152 by methylmercury causes inhibition of its catalytic activity and reduction of monoubiquitin levels in SH-SY5Y cells.
    Toyama T; Abiko Y; Katayama Y; Kaji T; Kumagai Y
    J Toxicol Sci; 2015 Dec; 40(6):887-93. PubMed ID: 26558469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
    Yasuda T; Nihira T; Ren YR; Cao XQ; Wada K; Setsuie R; Kabuta T; Wada K; Hattori N; Mizuno Y; Mochizuki H
    J Neurochem; 2009 Feb; 108(4):932-44. PubMed ID: 19141079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.
    Choi J; Levey AI; Weintraub ST; Rees HD; Gearing M; Chin LS; Li L
    J Biol Chem; 2004 Mar; 279(13):13256-64. PubMed ID: 14722078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione-mediated reversibility of covalent modification of ubiquitin carboxyl-terminal hydrolase L1 by 1,2-naphthoquinone through Cys152, but not Lys4.
    Toyama T; Shinkai Y; Yazawa A; Kakehashi H; Kaji T; Kumagai Y
    Chem Biol Interact; 2014 May; 214():41-8. PubMed ID: 24582816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage.
    Kim HJ; Kim HJ; Jeong JE; Baek JY; Jeong J; Kim S; Kim YM; Kim Y; Nam JH; Huh SH; Seo J; Jin BK; Lee KJ
    PLoS One; 2014; 9(6):e99654. PubMed ID: 24959670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1.
    Koharudin LM; Liu H; Di Maio R; Kodali RB; Graham SH; Gronenborn AM
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6835-40. PubMed ID: 20231490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.
    Nishikawa K; Li H; Kawamura R; Osaka H; Wang YL; Hara Y; Hirokawa T; Manago Y; Amano T; Noda M; Aoki S; Wada K
    Biochem Biophys Res Commun; 2003 Apr; 304(1):176-83. PubMed ID: 12705903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease-associated mutations in α-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1.
    Konya C; Hatanaka Y; Fujiwara Y; Uchida K; Nagai Y; Wada K; Kabuta T
    Neurochem Int; 2011 Aug; 59(2):251-8. PubMed ID: 21693148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy.
    Kabuta T; Wada K
    Autophagy; 2008 Aug; 4(6):827-9. PubMed ID: 18635949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish.
    Son OL; Kim HT; Ji MH; Yoo KW; Rhee M; Kim CH
    Biochem Biophys Res Commun; 2003 Dec; 312(3):601-7. PubMed ID: 14680807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
    Lee YC; Hsu SD
    Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents.
    Galter D; Westerlund M; Belin AC; Olson L
    Physiol Behav; 2007 Sep; 92(1-2):46-53. PubMed ID: 17599367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functions of UCH-L1 and its relation to neurodegenerative diseases.
    Setsuie R; Wada K
    Neurochem Int; 2007; 51(2-4):105-11. PubMed ID: 17586089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate recognition and catalysis by UCH-L1.
    Luchansky SJ; Lansbury PT; Stein RL
    Biochemistry; 2006 Dec; 45(49):14717-25. PubMed ID: 17144664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.